Negotiating a Material Adverse Change Clause in a $38M Deal

The situation

Kasia and Piotr had built their company over a decade, starting as a two-person operation, with Kasia writing the software that ran a network of clinics and Piotr overseeing the clinical and dispensing side of the business. By last year the company was large enough to make acquisitions of its own, and they had their eye on a specialty pharmacy business based in Brantford that filled a gap in their supply chain. The target compounded and delivered specialty medications to clinics across the region and had built a strong reputation over fifteen years under its founder, Navdeep.

The two sides reached an agreement in principle relatively quickly. The purchase price came in at roughly $38 million, split between an upfront cash payment and a smaller holdback tied to a transition period. Kasia and Piotr's existing corporate counsel had handled the company's earlier, smaller acquisitions, but this deal was larger and more complex than anything they had done before, and they brought our firm in once the letter of intent was signed, to work on the definitive share purchase agreement alongside their existing team.

The negotiation problem

Buried in the draft share purchase agreement was a clause that gets far less attention from business owners than it deserves: the material adverse change clause, often shortened to MAC. In plain terms, a MAC clause gives the buyer a right to walk away from the deal, or renegotiate its terms, if something happens to the target business between signing the agreement and closing that seriously damages its value. The gap between signing and closing in a deal this size typically runs several months, while regulatory approvals are obtained, financing is finalized, and the target's operations are reviewed in detail.

The draft clause, as first written by the acquirer's original counsel, defined a material adverse change in sweeping terms: any event, circumstance, or condition that had, or could reasonably be expected to have, a material adverse effect on the target's business, financial condition, or results of operations. Read literally, that language would let Kasia and Piotr walk away from the deal, or demand a lower price, over almost anything: a change in provincial drug reimbursement rates that affected every pharmacy in Ontario, a general economic downturn, even a shift in interest rates that changed the cost of financing the deal.

Navdeep's counsel pushed back hard on this point once negotiations reached the definitive agreement stage, and rightly so. A MAC clause that captures industry-wide or economy-wide events is not really about protecting the buyer from a deteriorating target business. It becomes a general escape hatch that shifts ordinary market risk onto the seller, who has no control over reimbursement policy or interest rates and who, in the months between signing and closing, cannot simply pause the business and wait to see what happens. Sellers reasonably expect that if the whole industry gets hit by the same wave, that is the buyer's risk to bear once the deal is signed, not a reason to reopen the price.

At the same time, Kasia and Piotr had a legitimate concern of their own. The target's revenue was concentrated: a single referral relationship with a network of walk-in clinics accounted for close to a fifth of its billings, and that contract was up for renewal within the following year. If that relationship fell apart, or if the business lost a key regulatory licence, or suffered a serious data breach affecting patient records, that was exactly the kind of company-specific deterioration a MAC clause exists to guard against, and Kasia and Piotr were not willing to close without some protection against it.

What we did

1. Mapped the risk categories separately before touching the drafting. Rather than negotiating the MAC definition line by line in the abstract, we worked with Kasia and Piotr to sort the risks they were actually worried about into two buckets: risks specific to the target business, which a MAC clause is meant to address, and risks that would affect any comparable pharmacy business in Ontario, which are properly priced into the deal at signing rather than used as a walk-away right later.
2. Proposed an industry-standard carve-out schedule. We drafted a list of excluded events that would not, on their own, count as a material adverse change: changes in law or regulatory reimbursement policy affecting the pharmacy sector generally, general economic or financial market conditions, changes in interest rates, and industry-wide supply disruptions. This is a well-established approach in Ontario and Canadian acquisition agreements, and Navdeep's counsel had reasonable comparable precedent to point to in support of it.
3. Added a disproportionate effect qualifier. Rather than excluding those industry-wide events outright with no exceptions, we negotiated language allowing them to count toward a material adverse change only to the extent they affected the target disproportionately compared to other businesses in the same sector. This protected Navdeep from being blamed for sector-wide conditions while still giving Kasia and Piotr recourse if, for example, a regulatory change hit the target's specific service line unusually hard.
4. Kept company-specific risks squarely inside the clause. We made sure the carve-out schedule did not extend to the risks that mattered most to our clients: loss or non-renewal of a top referral contract, loss of a required pharmacy operating licence, a data breach involving patient records, or material undisclosed litigation. Those stayed as clear, unqualified triggers.
5. Addressed the concentrated contract risk directly, rather than only through the MAC clause. A MAC clause is a blunt instrument, and relying on it alone to manage the referral contract risk would have meant either walking away from a deal Kasia and Piotr genuinely wanted, or closing with no protection at all if the contract quietly weakened without collapsing outright. We proposed a separate, narrower mechanism: an escrow holdback of roughly $2.5 million from the purchase price, held for up to twelve months and released as soon as the referral contract had been renewed or replaced on comparable terms.
6. Negotiated the interim operating covenants alongside the MAC clause. A MAC clause works together with covenants requiring the seller to run the business in the ordinary course between signing and closing. We tightened those covenants to require Navdeep to notify the buyer promptly of any material change in the referral relationship, so that a problem would surface well before closing rather than after.

The outcome

The final agreement was a genuine compromise, and both sides gave up ground to get there. Kasia and Piotr did not get the broad, unqualified MAC clause their original draft had proposed; industry-wide regulatory and economic events were carved out unless they hit the target disproportionately hard, which meant Kasia and Piotr absorbed general sector risk they had originally hoped to shift onto Navdeep. Navdeep, in turn, did not get an unconditional close; roughly $2.5 million of the $38 million purchase price sat in escrow for up to a year, tied to a contract renewal that was largely outside Navdeep's control to guarantee on any particular timeline, and the tightened notice covenants meant less operating latitude during the transition period than Navdeep's counsel had initially proposed.

The deal closed on schedule, with the transaction completing roughly five months after the letter of intent was signed. Nine months after closing, the referral contract was renewed on terms close to the original, and the escrow funds were released to Navdeep in full. Not every deal ends that cleanly. Had the contract lapsed instead, the escrow structure would have given Kasia and Piotr a defined, limited remedy rather than a dispute over whether the MAC clause had been triggered, and Navdeep would have known in advance exactly what was at stake rather than facing an open-ended claim. That predictability, for both sides, was the point of the negotiation.

What you can learn from this